Evidence-Based GI: An ACG Publication (EBGI) (@acg_ebgi) 's Twitter Profile
Evidence-Based GI: An ACG Publication (EBGI)

@acg_ebgi

Evidence-Based Gastroenterology is published by the American College of Gastroenterology @AmCollegeGastro Editor-in-Chief: Dr. Philip S. Schoenfeld @EBGIdoc

ID: 1618634554104758276

linkhttp://gi.org/ebgi calendar_today26-01-2023 15:39:17

460 Tweet

2,2K Takipçi

89 Takip Edilen

Evidence-Based GI: An ACG Publication (EBGI) (@acg_ebgi) 's Twitter Profile Photo

1/ ⏰ for #EBGI Tweetorial🧵w/ Daryl Ramai, MD, MPH, MSc. “When to Discontinue Colon Polyp Surveillance in Older Adults?” 📜 shorturl.at/CJd5g 🎧 shorturl.at/EWstZ 📰 shorturl.at/XQJ6s #GITwitter

1/ ⏰ for #EBGI Tweetorial🧵w/ <a href="/DarylRamai/">Daryl Ramai, MD, MPH, MSc.</a>

“When to Discontinue Colon Polyp Surveillance in Older Adults?”

📜 shorturl.at/CJd5g
🎧 shorturl.at/EWstZ
📰 shorturl.at/XQJ6s

#GITwitter
Mohamed Othman (@endoscopyothman) 's Twitter Profile Photo

In the last eight years, I was honored to help many endoscopists to start their ESD practice. One of the observations I noted is that endoscopists gain sufficient ESD skills and perform around 20 to 30 cases before they start scheudling the procedure intermittently and

In the last eight years, I was honored to help many endoscopists to start their ESD practice. One of the observations I noted is that endoscopists gain sufficient  ESD skills and perform around 20 to 30 cases before they start scheudling the procedure intermittently and
Evidence-Based GI: An ACG Publication (EBGI) (@acg_ebgi) 's Twitter Profile Photo

1/ ⏰ for #EBGI Tweetorial🧵w/ Natalie Wilson, MD! “Stemming the Tide: Is Long-Acting Octreotide Injection Better Than Standard of Care for Angiodysplasia-Related GI Bleeding?” 📜Summary bit.ly/3LDCtSH 🎧Podcast bit.ly/3Yf89FF 📰Article bit.ly/3ydmuYu

1/ ⏰ for #EBGI Tweetorial🧵w/ <a href="/nataliejowilson/">Natalie Wilson, MD</a>!

“Stemming the Tide: Is Long-Acting Octreotide Injection Better Than Standard of Care for Angiodysplasia-Related GI Bleeding?”

📜Summary bit.ly/3LDCtSH
🎧Podcast bit.ly/3Yf89FF
📰Article bit.ly/3ydmuYu
Evidence-Based GI: An ACG Publication (EBGI) (@acg_ebgi) 's Twitter Profile Photo

1/ ⏰ for #EBGI Tweetorial🧵w/ Fnu Vikash, MD & Sean-Patrick Prince, MBBS, MPH! “Tirzepatide Produces NASH Resolution and Decreases Fibrosis: Results from the SYNERGY-NASH Trial” 📜Summary: bit.ly/3yq9zTf 🎧 bit.ly/4cwtmyt 📰 bit.ly/46zUsDm #GITwitter

1/ ⏰ for #EBGI Tweetorial🧵w/ <a href="/FnuVikash/">Fnu Vikash, MD</a> &amp; <a href="/seanpattyp/">Sean-Patrick Prince, MBBS, MPH</a>!

“Tirzepatide Produces NASH Resolution and Decreases Fibrosis: Results from the SYNERGY-NASH Trial”

📜Summary: bit.ly/3yq9zTf
🎧 bit.ly/4cwtmyt
📰 bit.ly/46zUsDm

#GITwitter
Evidence-Based GI: An ACG Publication (EBGI) (@acg_ebgi) 's Twitter Profile Photo

1/ ⏰ for #EBGITweetorial🧵w/ Mythili Menon Pathiyil(she/her)! “Multi-Target Stool RNA Test for CRC Screening: When Should You Use It?” 📜Summary bit.ly/3ywKTs9 🎧 Podcast bit.ly/4cfYSjR 📰Article bit.ly/4dCGNxy #GITwitter

1/ ⏰ for #EBGITweetorial🧵w/ <a href="/menon_mythili/">Mythili Menon Pathiyil(she/her)</a>!

“Multi-Target Stool RNA Test for CRC Screening: When Should You Use It?”

📜Summary bit.ly/3ywKTs9
🎧 Podcast bit.ly/4cfYSjR
📰Article bit.ly/4dCGNxy

#GITwitter
Evidence-Based GI: An ACG Publication (EBGI) (@acg_ebgi) 's Twitter Profile Photo

1/ ⏰ for #EBGI Tweetorial🧵 w/Benjamin Clement, MD!​ “Can IV Metoclopramide Improve Endoscopic Visualization for Patients with Active Upper Gastrointestinal Bleeding?”​ 📜 Summary: shorturl.at/zkA6j​ 🎧 shorturl.at/g3ua1​ 📰 shorturl.at/FegCy​ #GITwitter

1/ ⏰ for #EBGI Tweetorial🧵 w/<a href="/BenClement_MD/">Benjamin Clement, MD</a>!​

“Can IV Metoclopramide Improve Endoscopic Visualization for Patients with Active Upper Gastrointestinal Bleeding?”​

📜 Summary: shorturl.at/zkA6j​
🎧 shorturl.at/g3ua1​
📰 shorturl.at/FegCy​

#GITwitter
Evidence-Based GI: An ACG Publication (EBGI) (@acg_ebgi) 's Twitter Profile Photo

1/ ⏰ for #EBGI Tweetorial🧵w/ Aimen Farooq!​ “Risankizumab Is Superior to Ustekinumab for Induction and Maintenance of Crohn’s Disease: The SEQUENCE Trial” 📰 bit.ly/4cF6tbR 🎧 bit.ly/4dDqL6T 📜 bit.ly/3MlAGCf

1/ ⏰ for #EBGI Tweetorial🧵w/ <a href="/AimenKhanMD/">Aimen Farooq</a>!​

“Risankizumab Is Superior to Ustekinumab for Induction and Maintenance of Crohn’s Disease: The SEQUENCE Trial”

📰 bit.ly/4cF6tbR
🎧 bit.ly/4dDqL6T
📜 bit.ly/3MlAGCf
Evidence-Based GI: An ACG Publication (EBGI) (@acg_ebgi) 's Twitter Profile Photo

1/⏰ for #EBGI Tweetorial🧵w/ Peter Bhandari, MD Long-term efficacy and safety of Ustekinumab for UC: 4 year data from the UNIFI Long-term Maintenance Study From Rahul S. Dalal, MD, MPH👇 📜 Summary shorturl.at/W7pEO 🎧 shorturl.at/bRqeL 📰 shorturl.at/Ar4zo #GITwitter

1/⏰ for #EBGI Tweetorial🧵w/ <a href="/PeterBhandariMD/">Peter Bhandari, MD</a>

Long-term efficacy and safety of Ustekinumab for UC: 4 year data from the UNIFI Long-term Maintenance Study

From <a href="/RahulSDalalMD/">Rahul S. Dalal, MD, MPH</a>👇
📜 Summary shorturl.at/W7pEO
🎧 shorturl.at/bRqeL
📰 shorturl.at/Ar4zo

#GITwitter